Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity

• Stavros Panagiotou,
• Chrispin Chaguza,
• Reham Yahya,
• Teerawit Audshasai,
• Murielle Baltazar,
• Lorenzo Ressel,
• Shadia Khandaker,
• Mansoor Alsahag,
• Tim J. Mitchell,
• Marc Prudhomme,
• Aras Kadioglu,
• Marie Yang

Affiliations

Stavros Panagiotou

Department of Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool

Chrispin Chaguza

Wellcome Sanger Institute, Wellcome Genome Campus

Reham Yahya

College of Sciences and Health Professions, King Saud Bin Abdulaziz University for Health Sciences

Teerawit Audshasai

Department of Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool

Murielle Baltazar

Department of Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool

Lorenzo Ressel

Department of Veterinary Pathology and Public Health, Institute of Veterinary Science, University of Liverpool

Shadia Khandaker

Department of Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool

Mansoor Alsahag

Department of Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool

Tim J. Mitchell

Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham

Marc Prudhomme

Université Paul Sabatier, Centre National de La Recherche Scientifique

Aras Kadioglu

Department of Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool

Marie Yang

Department of Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool